Xylosyltransferase I acceptor properties of fibroblast growth factor and its fragment bFGF (1-24) |
| |
Authors: | Kuhn Joachim Schnölzer Martina Schön Sylvia Müller Sandra Prante Christian Götting Christian Kleesiek Knut |
| |
Affiliation: | Institut für Laboratoriums- und Transfusionsmedizin, Herz- und Diabeteszentrum Nordrhein-Westfalen, Universit?tsklinik der Ruhr-Universit?t Bochum, Bad Oeynhausen, Germany. jkuhn@hdz-nrw.de |
| |
Abstract: | Human basic fibroblast growth factor (bFGF) is a heparin-binding growth factor containing a G-S-G-motif which is a potential recognition sequence of xylosyltransferase I (XT-I). Here, we show that the recombinant human bFGF was xylosylated in vitro by human XT-I and that the fragment bFGF (1-24) is a good XT-I acceptor (K(m) = 20.8 microM for native XT-I and K(m) = 22.3 microM for recombinant XT-I). MALDI and MALDI-PSD time-of-flight mass spectrometric analyses of the xylosylated bFGF protein demonstrate the transfer of xylose to the serine residue of the G-S-G-motif in the amino terminal end of bFGF. The peptide bFGF (1-24) is well suitable as an acceptor substrate for XT-I and can be used in a radiochemical assay to measure the XT-I activity in cell culture supernatant and human body fluids, respectively. Furthermore, we could demonstrate that the XT-I interacts strongly with heparin and that this glycosaminoglycan is a predominantly non-competitive inhibitor of the enzyme using the fragment bFGF (1-24) as xylose acceptor. |
| |
Keywords: | Xylosyltransferase Basic fibroblast growth factor Heparin |
本文献已被 ScienceDirect PubMed 等数据库收录! |